T
Toshihiro Hama
Researcher at Japanese Foundation for Cancer Research
Publications - 43
Citations - 458
Toshihiro Hama is an academic researcher from Japanese Foundation for Cancer Research. The author has contributed to research in topics: Regorafenib & Medicine. The author has an hindex of 9, co-authored 39 publications receiving 353 citations.
Papers
More filters
Journal ArticleDOI
Effect of paclitaxel on transient receptor potential vanilloid 1 in rat dorsal root ganglion.
Tomomi Hara,Terumasa Chiba,Kenji Abe,Akiko Makabe,Souichi Ikeno,Kazuyoshi Kawakami,Iku Utsunomiya,Toshihiro Hama,Kyoji Taguchi +8 more
TL;DR: Results suggest that paclitaxel treatment increases TRPV1 expression in DRG neurons and may contribute to functional peripheral neuropathic pain.
Journal ArticleDOI
Multicenter study for environmental and biological monitoring of occupational exposure to cyclophosphamide in Japan
Shin-ichi Sugiura,Hirokazu Nakanishi,Mika Asano,Tohru Hashida,Manabu Tanimura,Toshihiro Hama,Toshitaka Nabeshima +6 more
TL;DR: A multicenter field survey of environmental contamination and exposure of healthcare professionals to anticancer drugs were performed and CP was detected in 90 samples obtained from 23 subjects, indicating the amount of exposure was greatly different among the facilities.
Journal ArticleDOI
Paclitaxel Increases High Voltage–Dependent Calcium Channel Current in Dorsal Root Ganglion Neurons of the Rat
Kazuyoshi Kawakami,Terumasa Chiba,Nobuyuki Katagiri,Maya Saduka,Kenji Abe,Iku Utsunomiya,Toshihiro Hama,Kyoji Taguchi +7 more
TL;DR: Investigation of the effects of paclitaxel on the voltage-dependent calcium channel (VDCC) current in rat dorsal root ganglion (DRG) neurons using the whole-cell patch clamp technique found that pac litaxel treatment increases the VDCC current in small- and medium-diameter DRG neurons and upregulates Ca(v)α₂δ-1.
Journal ArticleDOI
Factors exacerbating peripheral neuropathy induced by paclitaxel plus carboplatin in non-small cell lung cancer.
Kazuyoshi Kawakami,Kazuyoshi Kawakami,Takashi Tunoda,Tomomi Takiguchi,Keiko Shibata,Takayuki Ohtani,Junko Kizu,Makoto Nishio,Takeshi Horai,Toshihiro Hama,Kyoji Taguchi +10 more
TL;DR: When and how often PN occurs in association with paclitaxel plus carboplatin (PC therapy), a regimen used to treat non-small cell lung cancer, and factors that exacerbate this condition are determined.
Journal ArticleDOI
Association of Immune-Related Adverse Events with Pembrolizumab Efficacy in the Treatment of Advanced Urothelial Carcinoma.
Kazuo Kobayashi,Kenichi Suzuki,Makoto Hiraide,Takeshi Aoyama,Takashi Yokokawa,Sari Shikibu,Koki Hashimoto,Yusuke Iikura,Hitoshi Sato,Erika Sugiyama,Masataka Tajima,Toshihiro Hama +11 more
TL;DR: Development of irAEs was associated with survival outcome of pembrolizumab treatment in patients with advanced urothelial cancer, and risk factors for exacerbation ofirAEs were positively associated with lymphocyte count at baseline (>2,000/µL).